Neogenomics NeoGenomics Q2 Revenues Grow 40 Percent The company reported $121.7 million in total revenues for the quarter and said clinical services revenues rose 37 percent from the prior-year quarter. NeoGenomics Expects Inivata Buy to Help it Penetrate MRD Monitoring Market Premium NeoGenomics believes Inivata's assays will contribute meaningful revenues as early as 2023, driven by both firms' existing relationships with oncology and pathology groups. Amgen, NeoGenomics Partner to Expand Biomarker Testing Access in NSCLC As part of its Biomarker Assist program, Amgen will cover the cost of NeoGenomics' KRAS tests for advanced or metastatic NSCLC patients regardless of their insurance status. Trapelo Health, Magellan Hope to Ease Prior Authorization for Precision Oncology Testing Premium The new partners seek to close the information loop by including providers, payors, and patients in biomarker-guided cancer therapy decisions. Trapelo Health, Magellan Rx Team on Value-Based Precision Oncology The technology vendor and the PBM will offer a bundled platform to help guide cancer patients to the most appropriate treatments. Mar 24, 2021 NeoGenomics Acquires Trapelo Health in $65M Deal Mar 16, 2021 NeoGenomics, Elevation Oncology Partner on NRG1 Fusion Testing for Clinical Trial Enrollment Feb 24, 2021 NeoGenomics Q4 Revenue Grows 18 Percent, CEO to Retire Feb 4, 2021 NeoGenomics, Parexel Partner to Improve Precision Oncology Trial Research Jan 22, 2021 NeoGenomics to Grow Pharma, Informatics Divisions Through CDx Agreements, Acquisitions Premium Jan 12, 2021 JP Morgan Healthcare Conference 2021, Day 2: Roche, Seer, 10x, Guardant, Hologic, Thermo Fisher Jan 7, 2021 NeoGenomics Prices $500M Offering of Stock, Senior Notes Dec 11, 2020 BTIG Initiates Coverage of NeoGenomics With Buy Rating Oct 27, 2020 NeoGenomics Q3 Revenues Rise 20 Percent Sep 18, 2020 People in the News: New Appointments at Quidel, NeoGenomics, Veracyte, More Jul 28, 2020 NeoGenomics Expects Q3 Revenue Growth as it Expands Liquid Biopsy Offerings, COVID-19 Testing Premium Jul 28, 2020 NeoGenomics Q2 Revenues Fall 14 Percent Jul 2, 2020 New Products Posted to GenomeWeb: Twist Bioscience, NeoGenomics, Flagship Biosciences Jun 9, 2020 NeoGenomics, Lilly Oncology Partner for Thyroid Cancer Testing Program May 26, 2020 NeoGenomics, Inivata Partner to Commercialize Lung Cancer Liquid Biopsy Test May 5, 2020 Bayer, NeoGenomics Launch Free NTRK Fusion Testing Program Apr 30, 2020 NeoGenomics Aims to Raise $300M Through Common Stock, Senior Notes Offerings Apr 28, 2020 NeoGenomics Q1 Revenues Grow 11 Percent Apr 9, 2020 NeoGenomics Preliminary Q1 Revenues Increase 11 Percent; Firm Withdraws 2020 Guidance Mar 2, 2020 NeoGenomics Nabs Cancer Testing Contract With HealthTrust Purchasing Group Load More Breaking News FDA Warns of Potential False Positives With Abbott SARS-CoV-2 Molecular Tests New Products Posted to GenomeWeb: Oxford Nanopore, Beckman Coulter, Thermo Fisher Scientific, More People in the News: New Appointments at Sema4, NHGRI, Dante Labs, Ancestry, More Thermo Fisher Scientific Expects 12 Percent Revenue Growth in 2022 In Brief This Week: Myriad Genetics, Danaher, Co-Diagnostics, and More Vibrent Health, University of Maryland Medicine Partner for Population Health Initiative The Scan For Those Thick Tiger Stripes Tigers in India with thick stripes harbor a genetic change, as Gizmodo reports. High GABA Tomatoes The Japan News reports that genome-edited tomatoes with higher GABA levels are now for sale in Japan. Approach for Inclusivity and Diversity A National Human Genome Research Institute team calls for the field to "adopt diversity as an ethos." Science Papers on Tumors Immune System Evasion; Drivers of Genomic Instability, Inflammation In Science this week: study of how tumors evade the adaptive immune system, and more.